Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Girinsky, T; Guillot-Vals, D; Koscielny, S; Cosset, JM; Ganem, G; Carde, P; Monhonval, M; Pereira, R; Bosq, J; Ribrag, V; Vantelon, JM; Munck, JN
   A high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: Analysis of predictive parameters of response to treatment
   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
   
   T. Girinsky et al., "A high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: Analysis of predictive parameters of response to treatment", INT J RAD O, 51(1), 2001, pp. 148-155
2. Lassau, N; Koscielny, S; Opolon, P; De Baere, T; Peronneau, P; Leclere, J; Roche, A
   Evaluation of contrast-enhanced color Doppler ultrasound for the quantification of angiogenesis in vivo
   INVESTIGATIVE RADIOLOGY
   
   N. Lassau et al., "Evaluation of contrast-enhanced color Doppler ultrasound for the quantification of angiogenesis in vivo", INV RADIOL, 36(1), 2001, pp. 50-55
3. Koscielny, S; Beleites, E
   Investigations on the influence of biomaterials on biological activity of microorganisms
   HNO
   
   S. Koscielny e E. Beleites, "Investigations on the influence of biomaterials on biological activity of microorganisms", HNO, 49(5), 2001, pp. 367-371
4. Koscielny, S; Brauer, B; Koch, J; Kahler, G
   Abdominal wall metastasis as a complication of percutaneous endoscopic gastrostomy
   HNO
   
   S. Koscielny et al., "Abdominal wall metastasis as a complication of percutaneous endoscopic gastrostomy", HNO, 49(5), 2001, pp. 392-395
5. Koscielny, S; Thames, HD
   Biased methods for estimating local and distant failure rates in breast carcinoma and a "commonsense" approach
   CANCER
   
   S. Koscielny e H.D. Thames, "Biased methods for estimating local and distant failure rates in breast carcinoma and a "commonsense" approach", CANCER, 92(8), 2001, pp. 2220-2227
6. De Crevoisier, R; Domenge, C; Wibault, P; Koscielny, S; Lusinchi, A; Janot, F; Bobin, S; Luboinski, B; Eschwege, F; Bourhis, J
   Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma
   CANCER
   
   R. De Crevoisier et al., "Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma", CANCER, 91(11), 2001, pp. 2071-2076
7. Koscielny, S; Fiedler, W; Dahse, R; Beleites, E
   The reactivation of telomerase in squamous cell carcinomas of the head andneck.
   LARYNGO-RHINO-OTOLOGIE
   
   S. Koscielny et al., "The reactivation of telomerase in squamous cell carcinomas of the head andneck.", LARY RH OTO, 79(9), 2000, pp. 551-556
8. Koscielny, S; Gudziol, H; Kretzschmar, J
   Cervical lymph nodes of unknown primary
   LARYNGO-RHINO-OTOLOGIE
   
   S. Koscielny et al., "Cervical lymph nodes of unknown primary", LARY RH OTO, 79(8), 2000, pp. 483-489
9. Vantelon, JM; Koscielny, S; Brault, P; Bourhis, JH; Ribrag, V; Pico, J; Fenaux, P; Munck, JN
   Scoring system for the prediction of successful peripheral blood stem cell(PBSC) collection in non-Hodgkin's lymphoma (NHL): application in clinicalpractice
   BONE MARROW TRANSPLANTATION
   
   J.M. Vantelon et al., "Scoring system for the prediction of successful peripheral blood stem cell(PBSC) collection in non-Hodgkin's lymphoma (NHL): application in clinicalpractice", BONE MAR TR, 25(5), 2000, pp. 495-499
10. Koscielny, S; Verges, L
    Adenomatous goiter with retropharyngeal extension
    HNO
    
    S. Koscielny e L. Verges, "Adenomatous goiter with retropharyngeal extension", HNO, 48(9), 2000, pp. 704-705
11. Dahse, R; Fieldler, W; Von Eggeling, F; Schimmel, B; Koscielny, S; Beleites, E; Claussen, U; Ernst, G
    P53 genotyping - An effective concept for molecular testing of head and neck cancer?
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    
    R. Dahse et al., "P53 genotyping - An effective concept for molecular testing of head and neck cancer?", INT J MOL M, 4(3), 1999, pp. 279-283
12. Riese, U; Dahse, R; Fiedler, W; Theuer, C; Koscielny, S; Ernst, G; Beleites, E; Claussen, U; von Eggeling, F
    Tumor suppressor gene p16 (CDKN2A) mutation status and promoter inactivation in head and neck cancer
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    
    U. Riese et al., "Tumor suppressor gene p16 (CDKN2A) mutation status and promoter inactivation in head and neck cancer", INT J MOL M, 4(1), 1999, pp. 61-65
13. Ulusakarya, A; Lumbroso, J; Casiraghi, O; Koscielny, S; Vantelon, JM; Girinsky, T; Tardivon, A; Bourhis, JH; Dartevelle, P; Pico, JL; Munck, JN
    Gallium scan in the evaluation of post chemotherapy mediastinal residual masses off aggressive non-Hodgkin's lymphoma
    LEUKEMIA & LYMPHOMA
    
    A. Ulusakarya et al., "Gallium scan in the evaluation of post chemotherapy mediastinal residual masses off aggressive non-Hodgkin's lymphoma", LEUK LYMPH, 35(5-6), 1999, pp. 579
14. Koscielny, S
    Metastasis of the renal carcinoma in the paranasal sinuses..
    LARYNGO-RHINO-OTOLOGIE
    
    S. Koscielny, "Metastasis of the renal carcinoma in the paranasal sinuses..", LARY RH OTO, 78(8), 1999, pp. 441-444
15. Lassau, N; Mercier, S; Koscielny, S; Avril, MF; Margulis, A; Mamelle, G; Duvillard, P; Leclere, J
    Prognostic value of high-frequency sonography and color Doppler sonographyfor the preoperative assessment of melanomas
    AMERICAN JOURNAL OF ROENTGENOLOGY
    
    N. Lassau et al., "Prognostic value of high-frequency sonography and color Doppler sonographyfor the preoperative assessment of melanomas", AM J ROENTG, 172(2), 1999, pp. 457-461
16. Koscielny, S; Tubiana, M
    Link between local recurrence and distant metastases in human breast cancer
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    
    S. Koscielny e M. Tubiana, "Link between local recurrence and distant metastases in human breast cancer", INT J RAD O, 45(1), 1999, pp. 245-246
17. Koscielny, S; Tubiana, M
    The link between local recurrence and distant metastases in human breast cancer
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    
    S. Koscielny e M. Tubiana, "The link between local recurrence and distant metastases in human breast cancer", INT J RAD O, 43(1), 1999, pp. 11-24
18. Tubiana, M; Koscielny, S
    The rationale for early diagnosis of cancer - The example of breast cancer
    ACTA ONCOLOGICA
    
    M. Tubiana e S. Koscielny, "The rationale for early diagnosis of cancer - The example of breast cancer", ACTA ONCOL, 38(3), 1999, pp. 295-303
19. Trog, D; Bank, P; Wendt, TG; Koscielny, S; Beleites, E
    Daily amifostine given concomitantly to chemoradiation in head and neck cancer - A pilot study
    STRAHLENTHERAPIE UND ONKOLOGIE
    
    D. Trog et al., "Daily amifostine given concomitantly to chemoradiation in head and neck cancer - A pilot study", STRAH ONKOL, 175(9), 1999, pp. 444-449
20. Lassau, N; Paturel-Asselin, C; Guinebretiere, JM; Leclere, J; Koscielny, S; Roche, A; Chouaib, S; Peronneau, P
    New hemodynamic approach to angiogenesis - Color and pulsed Doppler ultrasonography
    INVESTIGATIVE RADIOLOGY
    
    N. Lassau et al., "New hemodynamic approach to angiogenesis - Color and pulsed Doppler ultrasonography", INV RADIOL, 34(3), 1999, pp. 194-198
21. Koscielny, S; Wagner, C; Beleites, E
    Investigation of the time interval between the onset of symptoms and the beginning of therapy in patients with head and neck cancer
    HNO
    
    S. Koscielny et al., "Investigation of the time interval between the onset of symptoms and the beginning of therapy in patients with head and neck cancer", HNO, 47(6), 1999, pp. 551-555
22. Koscielny, S; Terrier, P; Spielmann, M; Delarue, JC
    Prognostic importance of low c-erbB2 expression in breast tumors - Response
    JOURNAL OF THE NATIONAL CANCER INSTITUTE
    
    S. Koscielny et al., "Prognostic importance of low c-erbB2 expression in breast tumors - Response", J NAT CANC, 91(18), 1999, pp. 1585-1585
23. LIEHR T; RIES J; WOLFF E; FIEDLER W; DAHSE R; ERNST G; STEININGER H; KOSCIELNY S; GIROD S; GEBHART E
    GAIN OF DNA COPY NUMBER ON CHROMOSOMES 3Q26-QTER AND 5P14-PTER IS A FREQUENT FINDING IN HEAD AND NECK SQUAMOUS-CELL CARCINOMAS
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    
    T. Liehr et al., "GAIN OF DNA COPY NUMBER ON CHROMOSOMES 3Q26-QTER AND 5P14-PTER IS A FREQUENT FINDING IN HEAD AND NECK SQUAMOUS-CELL CARCINOMAS", INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2(2), 1998, pp. 173-179
24. GEBHART E; LIEHR T; WOLFF E; RIES J; FIEDLER W; STEININGER H; KOSCIELNY S; GIROD S
    PATTERN OF GENOMIC IMBALANCES IN ORAL SQUAMOUS-CELL CARCINOMAS WITH AND WITHOUT AN INCREASED COPY NUMBER OF 11Q13
    International journal of oncology
    
    E. Gebhart et al., "PATTERN OF GENOMIC IMBALANCES IN ORAL SQUAMOUS-CELL CARCINOMAS WITH AND WITHOUT AN INCREASED COPY NUMBER OF 11Q13", International journal of oncology, 12(5), 1998, pp. 1151-1155
25. KOSCIELNY S; TERRIER P; DAVER A; WAFFLART J; GOUSSARD J; RICOLLEAU G; DELVINCOURT C; DELARUE JC
    QUANTITATIVE-DETERMINATION OF C-ERBB-2 IN HUMAN BREAST-TUMORS - POTENTIAL PROGNOSTIC-SIGNIFICANCE OF LOW VALUES
    European journal of cancer
    
    S. Koscielny et al., "QUANTITATIVE-DETERMINATION OF C-ERBB-2 IN HUMAN BREAST-TUMORS - POTENTIAL PROGNOSTIC-SIGNIFICANCE OF LOW VALUES", European journal of cancer, 34(4), 1998, pp. 476-481
26. DECREVOISIER R; BOURHIS J; DOMENGE C; WIBAULT P; KOSCIELNY S; LUSINCHI A; MAMELLE G; JANOT F; JULIERON M; LERIDANT AM; MARANDAS P; ARMAND JP; SCHWAAB G; LUBOINSKI B; ESCHWEGE F
    FULL-DOSE REIRRADIATION FOR UNRESECTABLE HEAD AND NECK-CARCINOMA - EXPERIENCE AT THE GUSTAVE-ROUSSY-INSTITUTE IN A SERIES OF 169 PATIENTS
    Journal of clinical oncology
    
    R. Decrevoisier et al., "FULL-DOSE REIRRADIATION FOR UNRESECTABLE HEAD AND NECK-CARCINOMA - EXPERIENCE AT THE GUSTAVE-ROUSSY-INSTITUTE IN A SERIES OF 169 PATIENTS", Journal of clinical oncology, 16(11), 1998, pp. 3556-3562
27. ULUSAKARYA A; MUNCK JN; CASIRAGHI O; KOSCIELNY S; VANTELON JM; DARTEVELLE P; GIRINSKY T; CARDE P; PICO JL; HAYAT M
    LOW SPECIFICITY AND SENSITIVITY OF GA-67 SCAN IN THE EVALUATION OF POST CHEMOTHERAPY MEDIASTINAL RESIDUAL MASSES IN AGGRESSIVE NON-HODGKINS-LYMPHOMA
    British Journal of Haematology
    
    A. Ulusakarya et al., "LOW SPECIFICITY AND SENSITIVITY OF GA-67 SCAN IN THE EVALUATION OF POST CHEMOTHERAPY MEDIASTINAL RESIDUAL MASSES IN AGGRESSIVE NON-HODGKINS-LYMPHOMA", British Journal of Haematology, 102(1), 1998, pp. 246-246
28. KOSCIELNY S; FIEDLER W; DAHSE R; SONNTAG J; HOFMANN SME; CLAUSSEN U; BELEITES E; ERNST G
    IS TELOMERASE ACTIVITY A POSSIBLE MARKER FOR THE METASTASIS OF HEAD AND NECK-CANCER
    British Journal of Cancer
    
    S. Koscielny et al., "IS TELOMERASE ACTIVITY A POSSIBLE MARKER FOR THE METASTASIS OF HEAD AND NECK-CANCER", British Journal of Cancer, 77, 1998, pp. 177-177
29. KOSCIELNY S; STEIN J; KRATSCH B
    DIAGNOSIS AND MANAGEMENT OF DISTANT METASTASIS OF THE CARCINOMA OF THE OROPHARYNX AND LARYNX - EXPERIENCE FROM 1980-1990
    British Journal of Cancer
    
    S. Koscielny et al., "DIAGNOSIS AND MANAGEMENT OF DISTANT METASTASIS OF THE CARCINOMA OF THE OROPHARYNX AND LARYNX - EXPERIENCE FROM 1980-1990", British Journal of Cancer, 77, 1998, pp. 1712-1712
30. MASSE A; RAMIREZ LH; BINDOULA G; GRILLON C; WDZIECZAKBAKALA J; RADDASSI K; DEPAILLETTE ED; MENCIAHUERTA JM; KOSCIELNY S; POTIER P; SAINTENY F; CARDE P
    THE TETRAPEPTIDE ACETYL-N-SER-ASP-LYS-PRO (GORALATIDE) PROTECTS FROM DOXORUBICIN-INDUCED TOXICITY - IMPROVEMENT IN MICE SURVIVAL AND PROTECTION OF BONE-MARROW STEM-CELLS AND PROGENITORS
    Blood
    
    A. Masse et al., "THE TETRAPEPTIDE ACETYL-N-SER-ASP-LYS-PRO (GORALATIDE) PROTECTS FROM DOXORUBICIN-INDUCED TOXICITY - IMPROVEMENT IN MICE SURVIVAL AND PROTECTION OF BONE-MARROW STEM-CELLS AND PROGENITORS", Blood, 91(2), 1998, pp. 441-449
31. KOSCIELNY S; TERRIER P; SPIELMANN M; DELARUE JC
    PROGNOSTIC IMPORTANCE OF LOW C-ERBB2 EXPRESSION IN BREAST-TUMORS
    Journal of the National Cancer Institute
    
    S. Koscielny et al., "PROGNOSTIC IMPORTANCE OF LOW C-ERBB2 EXPRESSION IN BREAST-TUMORS", Journal of the National Cancer Institute, 90(9), 1998, pp. 712-712
32. DECAUDIN D; BOSQ J; MUNCK JN; BAYLE C; KOSCIELNY S; BOUDJEMAA S; BENNACEUR A; VENUAT AM; NACCACHE P; BENDAHMANE B; RIBRAG V; CARDE P; PICO JL; HAYAT M
    MANTLE CELL LYMPHOMAS - CHARACTERISTICS, NATURAL-HISTORY AND PROGNOSTIC FACTORS OF 45 CASES
    Leukemia & lymphoma
    
    D. Decaudin et al., "MANTLE CELL LYMPHOMAS - CHARACTERISTICS, NATURAL-HISTORY AND PROGNOSTIC FACTORS OF 45 CASES", Leukemia & lymphoma, 26(5-6), 1997, pp. 539
33. RIBRAG V; TOUITOU R; BOSQ J; KOSCIELNY S; OUABDESSELAM R; NASR F; CORTI C; BRAULT P; CARDE P; HAYAT M; JOAB I; PALLARDY M
    HIGH SERUM INTERLEUKIN-2 RECEPTOR AND INTERLEUKIN-6 LEVELS ARE ASSOCIATED WITH A POOR FREEDOM FROM PROGRESSION IN ADULT NON-HODGKINS-LYMPHOMA (NHL)
    Blood
    
    V. Ribrag et al., "HIGH SERUM INTERLEUKIN-2 RECEPTOR AND INTERLEUKIN-6 LEVELS ARE ASSOCIATED WITH A POOR FREEDOM FROM PROGRESSION IN ADULT NON-HODGKINS-LYMPHOMA (NHL)", Blood, 90(10), 1997, pp. 3945-3945
34. MUNCK JN; DHERMAIN F; KOSCIELNY S; GIRINSKY T; CARDE P; BOSQ J; DECAUDIN D; JULIERON M; COSSET JM; HAYAT M
    ALTERNATING CHEMOTHERAPY AND RADIOTHERAPY FOR LIMITED-STAGE INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMAS - LONG-TERM RESULTS FOR 96 PATIENTS WITH TUMORS GREATER-THAN-5 CM
    Annals of oncology
    
    J.N. Munck et al., "ALTERNATING CHEMOTHERAPY AND RADIOTHERAPY FOR LIMITED-STAGE INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMAS - LONG-TERM RESULTS FOR 96 PATIENTS WITH TUMORS GREATER-THAN-5 CM", Annals of oncology, 7(9), 1996, pp. 925-931
35. VASSAL G; KOSCIELNY S; CHALLINE D; VALTEAUCOUANET D; BOLAND I; DEROUSSENT A; LEMERLE J; GOUYETTE A; HARTMANN O
    BUSULFAN DISPOSITION AND HEPATIC VENOOCCLUSIVE DISEASE IN CHILDREN UNDERGOING BONE-MARROW TRANSPLANTATION
    Cancer chemotherapy and pharmacology
    
    G. Vassal et al., "BUSULFAN DISPOSITION AND HEPATIC VENOOCCLUSIVE DISEASE IN CHILDREN UNDERGOING BONE-MARROW TRANSPLANTATION", Cancer chemotherapy and pharmacology, 37(3), 1996, pp. 247-253
36. NACCACHE P; DECAUDIN D; KOSCIELNY S; BENDAHMANE B; AUGER J; MUNCK JN
    SEMEN CRYOPRESERVATION AND POSTTHERAPEUTI C GONADAL DYSFUNCTION IN NON-HODGKINS DISEASE - EXPERIENCE AT THE INSTITUT GUSTAVE-ROUSSY FROM 1989 TO 1993
    Bulletin du cancer
    
    P. Naccache et al., "SEMEN CRYOPRESERVATION AND POSTTHERAPEUTI C GONADAL DYSFUNCTION IN NON-HODGKINS DISEASE - EXPERIENCE AT THE INSTITUT GUSTAVE-ROUSSY FROM 1989 TO 1993", Bulletin du cancer, 83(4), 1996, pp. 307-314
37. BENDAHMANE B; BOURHIS JH; MUNCK JN; KOSCIELNY S; DECAUDIN D; BRAULT P; CASTAGNA L; BOSQ J; IBRAHIM A; NACCACHE P; ULUSAKARYA A; PICO JL; HAYAT M
    MAMI SALVAGE THERAPY AND HIGH-DOSE CHEMOTHERAPY (HDCT) FOLLOWED BY AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN REFRACTORY OR RELAPSING NON-HODGKINS-LYMPHOMA (NHL)
    Blood
    
    B. Bendahmane et al., "MAMI SALVAGE THERAPY AND HIGH-DOSE CHEMOTHERAPY (HDCT) FOLLOWED BY AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN REFRACTORY OR RELAPSING NON-HODGKINS-LYMPHOMA (NHL)", Blood, 88(10), 1996, pp. 3852-3852
38. NACCACHE P; MUNCK JN; BRAULT P; DECAUDIN D; KOSCIELNY S; BOSQ J; BENNACEUR AL; CARDE P; PICO JL; ULUZAKARYA A; BOURHIS JH; GILLES E; HAYAT M
    LONG-TERM FOLLOW-UP OF A SUPER CHVMP-VB REGIMEN IN PATIENTS WITH HIGH-RISK NON-HODGKINS-LYMPHOMA OF AGGRESSIVE HISTOLOGY
    Blood
    
    P. Naccache et al., "LONG-TERM FOLLOW-UP OF A SUPER CHVMP-VB REGIMEN IN PATIENTS WITH HIGH-RISK NON-HODGKINS-LYMPHOMA OF AGGRESSIVE HISTOLOGY", Blood, 88(10), 1996, pp. 1796-1796
39. BOURHIS J; LUBIN R; ROCHE B; KOSCIELNY S; BOSQ J; DUBOIS I; TALBOT M; MARANDAS P; SCHWAAB G; WIBAULT P; LUBOINSKI B; ESCHWEGE F; SOUSSI T
    ANALYSIS OF P53 SERUM ANTIBODIES IN PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA
    Journal of the National Cancer Institute
    
    J. Bourhis et al., "ANALYSIS OF P53 SERUM ANTIBODIES IN PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA", Journal of the National Cancer Institute, 88(17), 1996, pp. 1228-1233
40. TARDIVON AA; MUNCK JN; SHAPEERO LG; KOSCIELNY S; BOSQ J; DHERMAIN F; GILLES R; HAYAT M; VANEL D
    CAN CLINICAL-DATA HELP TO SCREEN PATIENTS WITH LYMPHOMA FOR MR-IMAGING OF BONE-MARROW
    Annals of oncology
    
    A.A. Tardivon et al., "CAN CLINICAL-DATA HELP TO SCREEN PATIENTS WITH LYMPHOMA FOR MR-IMAGING OF BONE-MARROW", Annals of oncology, 6(8), 1995, pp. 795-800
41. RAMIREZ LH; JULIERON M; BONNAY M; KOSCIELNY S; ZHAO ZX; GOUYETTE A; MUNCK JN
    STIMULATION OF TUMOR-GROWTH IN-VITRO AND IN-VIVO BY SURAMIN ON THE VX2 MODEL
    Investigational new drugs
    
    L.H. Ramirez et al., "STIMULATION OF TUMOR-GROWTH IN-VITRO AND IN-VIVO BY SURAMIN ON THE VX2 MODEL", Investigational new drugs, 13(1), 1995, pp. 51-53
42. MATHIEU MC; KOSCIELNY S; LEBIHAN ML; SPIELMANN M; ARRIAGADA R
    P53 PROTEIN OVEREXPRESSION AND CHEMOSENSITIVITY IN BREAST-CANCER
    Lancet
    
    M.C. Mathieu et al., "P53 PROTEIN OVEREXPRESSION AND CHEMOSENSITIVITY IN BREAST-CANCER", Lancet, 345(8958), 1995, pp. 1182-1182
43. MUNCK JN; DEACAUDIN D; KOSCIELNY S
    RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR IN ACUTE MYELOGENOUS LEUKEMIA
    The New England journal of medicine
    
    J.N. Munck et al., "RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR IN ACUTE MYELOGENOUS LEUKEMIA", The New England journal of medicine, 333(17), 1995, pp. 1155-1156
44. KOSCIELNY S; THULLIEZ P; CABANIS EA; IBAZIZEN MT; DUSSAIX E; BLOCHMICHEL E; TRICHET C; HELLEBOID L
    LOCAL IGG PRODUCTION IN AQUEOUS-HUMOR IN PATIENTS WITH IDIOPATHIC UVEITIS COMPARED WITH MRI FINDINGS
    Journal of Neurology, Neurosurgery and Psychiatry
    
    S. Koscielny et al., "LOCAL IGG PRODUCTION IN AQUEOUS-HUMOR IN PATIENTS WITH IDIOPATHIC UVEITIS COMPARED WITH MRI FINDINGS", Journal of Neurology, Neurosurgery and Psychiatry, 58(6), 1995, pp. 758-758
45. KOSCIELNY S
    LOCAL RECURRENCES FOLLOWING MASTECTOMY - SUPPORT FOR THE CONCEPT OF TUMOR DORMANCY
    Journal of the National Cancer Institute
    
    S. Koscielny, "LOCAL RECURRENCES FOLLOWING MASTECTOMY - SUPPORT FOR THE CONCEPT OF TUMOR DORMANCY", Journal of the National Cancer Institute, 87(4), 1995, pp. 316-317
46. MASSAAD L; CHABOT GG; TOUSSAINT C; KOSCIELNY S; MORIZET J; BISSERY MC; GOUYETTE A
    INFLUENCE OF TUMOR SIZE ON THE MAIN DRUG-METABOLIZING ENZYME-SYSTEMS IN MOUSE COLON ADENOCARCINOMA CO38
    Cancer chemotherapy and pharmacology
    
    L. Massaad et al., "INFLUENCE OF TUMOR SIZE ON THE MAIN DRUG-METABOLIZING ENZYME-SYSTEMS IN MOUSE COLON ADENOCARCINOMA CO38", Cancer chemotherapy and pharmacology, 34(6), 1994, pp. 497-502
47. BOUGNOUX P; KOSCIELNY S; CHAJES V; DESCAMPS P; COUET C; CALAIS G
    ALPHA-LINOLENIC ACID CONTENT OF ADIPOSE BREAST-TISSUE - A HOST DETERMINANT OF THE RISK OF EARLY METASTASIS IN BREAST-CANCER
    British Journal of Cancer
    
    P. Bougnoux et al., "ALPHA-LINOLENIC ACID CONTENT OF ADIPOSE BREAST-TISSUE - A HOST DETERMINANT OF THE RISK OF EARLY METASTASIS IN BREAST-CANCER", British Journal of Cancer, 70(2), 1994, pp. 330-334
48. DECAUDIN D; MUNCK JN; BAYLE C; BOURHIS JH; BOSQ J; KOSCIELNY S; BENNACEUR AL; MORDACQ M; IBRAHIM A; DHERMAIN F; PICO JL; HAYAT M
    MANTLE CELL LYMPHOMA - A RETROSPECTIVE STUDY OF 47 CASES BETWEEN 1978AND 1993 IN THE INSTITUT-GUSTAVE-ROUSSY
    Blood
    
    D. Decaudin et al., "MANTLE CELL LYMPHOMA - A RETROSPECTIVE STUDY OF 47 CASES BETWEEN 1978AND 1993 IN THE INSTITUT-GUSTAVE-ROUSSY", Blood, 84(10), 1994, pp. 10000450-10000450
49. TARDIVON A; MUNCK JN; KOSCIELNY S; DECAUDIN D; DHERMAIN F; BOSQ J; BOURHIS JH; IBRAHIM A; PICO JL; HAYAT M
    WHICH PATIENTS WITH LYMPHOMA SHOULD HAVE MAGNETIC-RESONANCE-IMAGING (MRI) OF BONE-MARROW
    Blood
    
    A. Tardivon et al., "WHICH PATIENTS WITH LYMPHOMA SHOULD HAVE MAGNETIC-RESONANCE-IMAGING (MRI) OF BONE-MARROW", Blood, 84(10), 1994, pp. 10000649-10000649